
Cefomas-S 1000mg/500mg Injection
Marketer
Aktimas Bio Pharmaceuticals Pvt Ltd
Salt Composition
Cefotaxime (1000mg) + Sulbactam (500mg)
Overview Cefomas-S 1000mg/500mg Injection
Combiflox, a 1000mg/500mg injectable dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under medical guidance; adherence to the prescribed dosage schedule is crucial for optimal efficacy. Premature cessation may compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, urticaria, angioedema, dyspnea). Inform your physician about all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Rest, nutrition, and hydration are vital for recovery. Follow-up laboratory tests may be conducted to monitor therapeutic response.
Uses of Cefomas-S 1000mg/500mg Injection
Combating Bacterial Infections
Major Benefits of Cefomas-S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefomas-S 1000mg/500mg Injection:
- Injection site reactions (pain, swelling, redness)
- Injection site pain
- Injection site inflammation
- Hardening at the injection site
- Injection site tenderness
- Hypersensitivity
- Gastrointestinal disorder
- Decreased white blood cell count (neutrophils)
How to use Cefomas-S 1000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cefomas-S 1000mg/500mg Injection works:
Cefotaxime and Sulbactam, combined as Cefomas-S 1000mg/500mg Injection, offer targeted antibacterial action. Cefotaxime, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, complements this by counteracting bacterial defenses and bolstering Cefotaxime's effectiveness.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Cefomas-S 1000mg/500mg Injection concurrently with alcohol. Seek medical advice.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Cefomas-S 1000mg/500mg Injection is generally regarded as safe. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Cefomas-S 1000mg/500mg injection poses minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, presenting no apparent danger to the infant.
DrivingUNSAFE
Administering Cefomas-S 1000mg/500mg Injection could lead to drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if such effects are experienced.
KidneyCAUTION
The injectable formulation of Cefomas-S (1000mg/500mg) requires careful administration in individuals with impaired renal function. Dosage modification for Cefomas-S (1000mg/500mg) injection may be necessary. Physician consultation is recommended. Close monitoring of kidney function is advisable during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefomas-S 1000mg/500mg Injection administration to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Cefomas-S 1000mg/500mg Injection :
Should you forget a scheduled dose of Cefomas-S 1000mg/500mg Injection, seek advice from your physician.
Facts to Know About Cefomas-S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Antimicrobial agents |
